Coadministration of anti-thymocyte globulin and belatacept in de novo kidney transplant recipients may pose risk for venous thrombosis of the renal allograft, especially in patients with predisposing risk factors.
Source: NLP:belatacept
Anti-Thymocyte Globulin Interactions
1 interaction on record